NCT04194814View on ClinicalTrials.gov

Skin bioMARkers for Atopic Eczema Therapy Evaluation

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

November 20, 2020

Primary Completion Date

September 30, 2021

Study Completion Date

September 30, 2021

Conditions
Atopic Eczema/Dermatitis (Non-Specific)
Interventions
DRUG

crisaborole (2%) ointment

twice daily application on one forearm for 4 weeks (randomised site allocation)

DRUG

betamethasone valerate 0.1% cream

twice daily application on one forearm for 4 weeks (randomised site allocation)

Trial Locations (1)

S10 2JF

Sheffield Dermatology Research, University of Sheffield Medical School, The Royal Hallamshire Hospital, Sheffield

All Listed Sponsors
collaborator

University of Sheffield

OTHER

lead

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

NCT04194814 - Skin bioMARkers for Atopic Eczema Therapy Evaluation | Biotech Hunter | Biotech Hunter